Introduction: The central nervous system (CNS) is anatomically divided into two components - the brain and the spinal cord - each possessing distinct histophysiological characteristics, yet functioning in close integration to maintain bodily homeostasis. Within this framework, the spinal cord may be subject to neoplastic processes capable of eliciting systemic effects, constituting a pathology potentially influenced by epidemiological factors in Brazil. Objectives: This study aims to describe the epidemiological profile of hospitalizations due to malignant neoplasms of other parts of the CNS (which includes the Spinal Cord) in the state of Pará between 2019 and 2024, and to identify potential risk factors associated with the disease. Methods: This was a cross-sectional, observational epidemiological study based on secondary data retrieved from the Department of Informatics of the Brazilian Unified Health System (DATASUS). Data were collected and analyzed according to the following variables: Place of Hospitalization Occurrence, Age Group, Race/Color, Sex, and Year of Processing. The study population included patients diagnosed with Malignant Neoplasm of Other Parts of the CNS (ICD-10 code C72). Data analysis was performed using Microsoft Office Excel 2019 and BioEstat 5.3. A descriptive and comparative analysis was conducted, and a chi-square test was applied to assess the association between Age Group, Race/Color, Sex and the clinical outcome (death or hospital discharge). A p-value of less than 0.05 was considered statistically significant. Results: A total of 377 hospitalizations were recorded in Pará between 2019 and 2024. Of these, 315 (83.55%) occurred in Belém, followed by 22 (5.83%) in Santarém. The highest number of hospitalizations was observed among children aged 5 to 9 years, with 69 cases (18.30%), followed by the 1 to 4 years age group with 50 cases (13.26%). Mixed race ("parda") individuals represented the majority of hospitalizations (292 cases, 77.45%), followed by white individuals (37 cases, 9.81%). Males were more affected, accounting for 210 hospitalizations and 25 deaths (62.5%), compared to females with 167 hospitalizations and 15 deaths (37.5%). No statistically significant association was found between age group (p = 0.1754), race/color (p = 0.3024) and sex (p =0.5115) in relation to the clinical outcome for each variable. The overall mortality rate during the study period was 10.61%, with 2022 presenting the highest mortality rate (19.61%) and the greatest number of deaths (10). The year 2023 recorded the highest number of hospitalizations, totaling 86 cases (22.81%). Conclusion: This study characterized the epidemiological profile of malignant neoplasms of other parts of the CNS in Pará between 2019 and 2024, identifying a predominant demographic of mixed-race male children. These findings highlight the urgent need for targeted public health policies and early detection strategies, emphasizing the role of social determinants in oncology care.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
